Furthermore, licochalcone E enhanced expression of PPAR-γ through irritating Akt signals as well as functions as a PPAR-γ partial agonist, which improved hyperlipidemia and hyperglycemia under diabetic conditions [12]. Here, PPARG is linked to hyperlipidemia.